S-Space

Browse

Author

Showing results 1 to 2 of 2

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2022-04	A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors Cho, Byoung Chul; Han, Ji-Youn; Kim, Sang-We; Lee, Ki Hyeong; Cho, Eun Kyung; Lee, Yun-Gyoo; Kim, Dong Wan; Kim, Joo-Hang; Lee, Gyeong-Won; Lee, Jong-Seok; Shim, Byoung Yong; Kim, Jin-Soo; Chun, Sang Hoon; Lee, Sung Sook; Kim, Hye Ryun; Hong, Min Hee; Ahn, Jin Seok; Sun, Jong-Mu; Lee, Youngjoo; Lee, Dae Ho; Kang, Ji Ah; Lee, NaMi; Kwon, Mi-Jung; Espenschied, Carin; Yablonovitch, Arielle; Ahn, Myung-Ju Journal of Thoracic Oncology, Vol.17 No.4, pp.558-567	DOI
2024-01	Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset Lee, Ki Hyeong; Cho, Byoung Chul; Ahn, Myung-Ju; Lee, Yun-Gyoo; Lee, Youngjoo; Lee, Jong-Seok; Kim, Joo-Hang; Min, Young Joo; Lee, Gyeong-Won; Lee, Sung Sook; Lee, Kyung-Hee; Ko, Yoon Ho; Shim, Byoung Yong; Kim, Sang-We; Shin, Sang Won; Choi, Jin-Hyuk; Kim, Dong-Wan; Cho, Eun Kyung; Park, Keon Uk; Kim, Jin-Soo; Chun, Sang Hoon; Wang, Jangyoung; Choi, SeokYoung; Kang, Jin Hyoung Cancer research and treatment, Vol.56 No.1, pp.48-60	DOI